ISO 14155 certification is an internationally recognized standard that defines Good Clinical Practice (GCP) requirements for the design, conduct, recording, and reporting of clinical investigations involving medical devices. The standard ensures that clinical investigations are conducted ethically, scientifically, and in compliance with applicable regulatory requirements.
ISO 14155:2020 focuses on protecting human subjects, ensuring data integrity, and generating reliable clinical evidence to demonstrate the safety and performance of medical devices.
Clinical investigations play a critical role in demonstrating that medical devices are safe and effective for their intended use. ISO 14155 Good Clinical Practice provides a harmonized framework accepted globally by regulators, manufacturers, and notified bodies.
Key objectives of ISO 14155 include:
Protection of patient rights, safety, and well-being
Ethical conduct of clinical investigations
Scientific validity and data credibility
Compliance with regulatory expectations
Transparency and traceability of clinical data
Compliance with ISO 14155 is essential for manufacturers seeking regulatory approval in global markets.
Medical device clinical investigation GCP under ISO 14155 applies to:
Pre-market and post-market clinical investigations
Performance and safety evaluations
Clinical follow-up studies
Investigations involving human subjects
The standard covers all stages of a clinical investigation, from planning and design to reporting and record retention.
Understanding ISO 14155 requirements is critical for effective implementation. The standard emphasizes the following core elements:
Clinical investigations must follow ethical principles based on the Declaration of Helsinki, ensuring informed consent and subject protection.
Clear responsibilities must be defined for sponsors, investigators, ethics committees, and monitors involved in clinical trials for medical devices ISO 14155.
A well-structured CIP must be prepared, defining objectives, methodology, risk management, and data analysis procedures.
Risks associated with the medical device must be identified, evaluated, and controlled throughout the investigation lifecycle.
Accurate data collection, documentation, and record control are mandatory to ensure reliability and traceability.
The ISO 14155 certification process typically involves:
Gap Analysis
Review existing clinical investigation processes against ISO 14155 requirements.
System Development
Develop procedures, templates, and clinical documentation.
Training & Implementation
Train investigators, sponsors, and study teams on GCP principles.
Internal Review & Audit
Conduct internal checks to ensure compliance.
Assessment & Certification
Undergo external assessment to demonstrate conformity.
ISO 14155 is essential for:
Medical device manufacturers
Clinical research organizations (CROs)
Sponsors of clinical investigations
Regulatory and compliance teams
Healthcare institutions conducting device trials
Any organization involved in clinical trials for medical devices ISO 14155 should comply with this standard.
Improved patient safety and ethical compliance
High-quality, credible clinical evidence
Faster regulatory approvals
Global acceptance of clinical data
Reduced compliance and legal risks
Enhanced reputation and trust
Meeting ISO 14155 requirements strengthens confidence among regulators and stakeholders.
Professional consultancy helps organizations:
Interpret complex regulatory requirements
Develop compliant clinical investigation systems
Train clinical and regulatory teams
Prepare for audits and inspections
Reduce delays and non-compliance risks
Expert guidance ensures smooth and efficient ISO 14155 implementation.
ISO 14155 certification confirms that clinical investigations of medical devices are conducted ethically and scientifically according to Good Clinical Practice.
ISO 14155 is not legally mandatory but is widely required by regulators and notified bodies for clinical investigations.
Medical device manufacturers, sponsors, CROs, and organizations conducting clinical investigations must comply.
Typically 3 to 6 months, depending on investigation scope and organizational readiness.
Yes, ISO 14155 applies to both pre-market and post-market clinical investigations.
Contact Intermax Consultancy today to discuss how we can help you achieve your certification and compliance goals.